March 21, 2014Open Access

Increased carriage of macrolide-resistant fecalE. colifollowing mass distribution of azithromycin for trachoma control

Puntos clave

Los puntos clave no están disponibles para este artículo en este momento.

Resumen

MDA resulted in significantly increased prevalence of macrolide resistance in E. coli. Although MDA is effective for trachoma elimination, it has costs; it is essential to monitor antimicrobial resistance following MDA.

Leer artículo completoexternamente

Preguntar a la IA

Me gusta

Guardar

Ver artículo completo

Cite This Study

Seidman et al. (Fri,) studied this question.

synapsesocial.com/papers/69da878585037e71b26840c7 https://doi.org/https://doi.org/10.1093/ije/dyu062

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1The Relationship between Antimicrobial Resistance and Patient Outcomes: Mortality, Length of Hospital Stay, and Health Care Costs2005 · 1,289 citations
2Patterns of antimicrobial use and antimicrobial resistance among healthy children in Bolivia1998 · 89 citations
3Skin and soft tissue infection: microbiology and epidemiology2009 · 213 citations
4Trends in Antibiotic Resistance Among Diarrheal Pathogens Isolated in Thailand Over 15 Years1998 · 380 citations
5A Prospective Study of the Impact of Community-Based Azithromycin Treatment of Trachoma on Carriage and Resistance of Streptococcus pneumoniae1997 · 250 citations

Preguntar a la IA

Me gusta

Guardar

Ver artículo completo